US16934Q5053
US16934Q5053
Chimera Investment Corporation
Loading chart...
Elevated Business & Solvency Risk
Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 50/100).
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
5/7 Elevated
5 / 7 SRI Price Fluctuation & Beta
Above-average volatility. Suitable for experienced investors with high risk tolerance (5+ years horizon). Moves approx. 1.8x as much as the broader market.
Beta (Market Relation)
1.81x
Above averageVolatility (5Y p.a.)
18.1% p.a.
5-Year HorizonMax Drawdown (5Y)
-37.1%
5-Year HorizonSharpe Ratio
-0.34
Return / RiskElevated Risk / Growth: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
High Volatility
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | -8% |
| 3 Years | 12.5% | -18.7% | 0.23 | +5.4% |
| 5 Years | 18.1% | -37.1% | -0.34 | -3.8% |
| 10 Years | 43.1% | -71.3% | -0.1 | — |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 557%.
High market risk: Beta of 1.81 indicates above-average volatility compared to the broader market.
Strong cyclicality: The business model is sensitive to economic downturns.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (18.1% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -71.3% in the extended horizon.
Corporate Governance & ISS Scores
Overall Governance Risk
-
Audit Risk
-
Board Risk
-
Short Ratio
0.92